After a patent dispute with medical device firm Masimo (MASI), Apple (AAPL) has ceased sales of its latest Apple Watch models — the Series 9 and Ultra 2 — containing a blood oxygen app. D.A. Davidson Managing Director Gil Luria argues this ruling spotlights existing concerns that Apple has fallen behind in innovation.

While seeing minor financial impacts, Luria calls the halt "an embarrassment for Apple" reflecting stalled creativity especially as the newest Apple Watch represented rare new advancements as compared to recent generations of the iPhone. With competition innovating quicker, Luria contends Apple has been "a little stuck."

Luria believes renewing revenue growth and market leadership depends on Apple getting "unstuck on the innovation front" after a years of similar smartphone designs that fail to "compel" annual upgrades unless damage occurs.

For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Related Videos

Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here.

Video Transcript

- Our next guest thinks Apple's strength is keeping users within its ecosystem while its competitors are winning in innovation. For more on how the tech giant is shaping up into 2024, Gil Luria-- D.A. Davidson Managing Director joins us now. Good morning, Gil. Over in your note, you called this an inopportune time for this to happen to Apple, particularly, with this crucial holiday week underway. How do you see this sales glitch play out into early 2024?

GIL LURIA: So the impact to Apple isn't going to be that material. They've been able to hold off. They only need to take it off their own shelves December 24. They're taking it off the website today, which means it's only a very narrow demographics that's actually going to lose sales. We're talking about husbands that wait until the last minute to buy their wife a gift that instead of buying the Ultra 2, they're going to go to the other part of the mall and buy something else.

That's not a lot of sales, but this is still embarrassing. It shouldn't come to this. These cases always get settled and somebody decided to gamble on the appeal and not settle with Massimo. And this is an embarrassment for Apple. Again, the sales loss may not be material, but it's still embarrassing. They're going to have consumers confused. They're going to go to the store, they're going to want the Ultra 2 or the Watch 9.

They're not going to be able to buy it. By the way, they can buy it at Best Buy or at other retailers, but they won't be able to buy at the Apple Store. You never want to frustrate your customers. That's really going to be the outcome here. And it ties to a bigger theme of innovation that you touched on too.